Overview

Basic information

Litigation

Active legal matters

Material Events

8-K disclosures

SEC Filings

Key regulatory docs

Insider Transactions

Ownership changes

Overview

Basic information

Litigation

Active legal matters

Material Events

8-K disclosures

SEC Filings

Key regulatory docs

Insider Transactions

Ownership changes

Securities Class Action

Securities fraud litigation history and active cases

In Litigation

0

Settlement

1

Closed

1

Total Settlement

$125M

Alexion Pharmaceuticals, Inc. (ALXN) Class Action Lawsuit (December 2016)

Settlement

3:16cv2127 • December 29, 2016

Class Period Start

January 30, 2014

Class Period End

August 23, 2017

PSLRA Deadline

January 17, 2017

Case Allegations

10b5

Statutes of Repose

Jan 30, 2017

Country

United States

Court

Federal Court

Settlement Information

Please note that for cases in the settlement stage, claims are handled by the claims administrator and NOT Levi & Korsinsky. Any information or documentation previously provided to us does not constitute submission of a claim. If you need to file a claim, check the status of a claim, or have questions regarding distribution of settlement funds, please contact the claims administrator below.

Claim Deadline

December 15, 2023

Settlement Fund

$125,000,000

Settlement Status

Final Approval

Settlement Class

All persons or entities that purchased or otherwise acquired the publicly traded common stock of Alexion Pharmaceuticals, Inc. (“Alexion” or the “Company”) from January 30, 2014 to May 26, 2017 inclusive.

Claim Administrator

Kurtzman Carson Consultants, LLC
Alexion Securities Settlement c/o KCC Class Action Services PO Box 301170 Los Angeles, CA 90030-1170
+1 866-573-1726
[email protected]

Hearing Date

December 20, 2023

Opt-out Deadline

November 29, 2023

Settlement Note

Download here

Proof Of Claim

Download here

Docket History

Dec 21, 2023

Final Approval of Settlement

The court has granted final approval of the settlement. Eligible investors who submit valid claims may receive a payment once the claims review and distribution process is completed.

Oct 3, 2023

Proof of Claim Form

To receive your portion of the recovery (if you are eligible), you must submit this form to the claims administrator by the deadline indicated on the form itself. If you do not submit this form in time, you will not be entitled to compensation. If you have questions about how to complete the form, you should contact the claims administrator.

Sep 19, 2023

Preliminary Approval of Settlement

The court has granted preliminary approval of a proposed settlement. This means the settlement can move forward for further consideration, but it has not yet received final approval. Potential class members will generally receive notice explaining the settlement, their rights, and any deadlines for submitting a claim, objecting to the settlement, or choosing not to participate.

Sep 13, 2023

Proposed Settlement

Apr 13, 2023

Class Certification Granted

The court has determined that a class action is the appropriate method to bring the claims by class members. Usually, when a class is certified, the judge will also affirm an individual or entity to represent the class and finalize a class definition (i.e.: who is represented in the lawsuit).

View all Updates

Alexion Pharmaceuticals, Inc. (ALXN) Class Action Lawsuit (November 2016)

Closed

1:16cv8946 • November 17, 2016

Class Period Start

February 10, 2014

Class Period End

November 9, 2016

PSLRA Deadline

January 17, 2017

Case Allegations

10b5

Statutes of Repose

Feb 10, 2017

Country

United States

Court

Federal Court

Docket History

Dec 30, 2016

Voluntary Dismissal

The plaintiff in this action has chosen not to proceed with the case. Once a case is voluntary dismissed, the courts will usually close the case and no further action will be taken.

Nov 17, 2016

First Filed Complaint

A securities fraud class action complaint has been filed on behalf of certain investors in Alexion Pharmaceuticals, Inc. .

TOP